Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples

Clinical trial NCT02762721 · COMPLETED

Trial details

NCT number: NCT02762721
Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Status: COMPLETED
Study type: OBSERVATIONAL

Intrahepatic Cholangiocarcinoma Mixed Hepatocellular Cholangiocarcinoma Cholangiocarcinoma

Start date: 2016-06-06
Primary completion: 2017-04-06
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.